扁桃体
医学
淋巴瘤
病态的
放射治疗
阶段(地层学)
喉咙痛
病理
内科学
肿瘤科
外科
生物
古生物学
作者
Tingting Han,Li Wang,Lei Fan,Jianping Xu,Jianyong Li,Wei Xu
出处
期刊:PubMed
日期:2014-02-01
卷期号:22 (1): 104-7
被引量:1
标识
DOI:10.7534/j.issn.1009-2137.2014.01.021
摘要
Tonsil is the most frequent site of the head and neck non-Hodgkin's lymphoma (NHL), and the diffuse large B cell lymphoma (DLBCL) is the most common pathological type in tonsil NHL. The aim of this study was to investigate the characteristics of clinical manifestation, immunophenotype, prognostic factor of primary tonsil DLBCL and its treatment strategy. The clinical data of 7 newly diagnosed patients with primary tonsil DLBCL from October 2009 to February 2013 were analyzed retrospectively. The results indicated that the pharynx or sore throat as the fist symptom was found in all patients. Out of 7 cases, 3 was in Ann Arbor stage I (42.8%), a case was in stage II (57.1%). Pathological immunohistochemical detection showed that the CD10 positive rate was 100%, BCL-2 positive rate was 83.3%, BCL-6 positive rate was 71.4%, Ki-67 ≥ 70% was 66.7%. They were all sensitive to chemotherapy and radiotherapy. Following up 4 to 40 months, they were all alive. It is concluded that most patients with primary tonsil DLBCL are at early stage, have an obvious characteristics of onset ages, clinical manifestations, pathological histology and achieve better remission through combined chemotherapy and radiotherapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI